| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |